CR

CRISM Therapeutics Corporation

Overview

Corporate Details

ISIN(s):
VGG042401262
LEI:
213800XFW6MKVCHHPW88
Country:
Virgin Islands (British)
Address:
C/O MAPLES FINANCE BVI LIMITED, VG1110 ROAD TOWN
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

No description available.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for CRISM Therapeutics Corporation. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-26 17:03
Post-Annual General Meeting Information
Result of AGM
English 25.8 KB
2025-08-26 08:00
Post-Annual General Meeting Information
AGM Statement
English 15.6 KB
2025-08-12 08:00
Regulatory News Service
GMP Manufacture of ChemoSeed
English 16.9 KB
2025-07-10 16:04
Major Shareholding Notification
Holding(s) in Company
English 23.3 KB
2025-07-03 08:00
Share Issue/Capital Change
Result of Retail Offer and Additional Placing
English 16.8 KB
2025-07-01 17:41
Capital/Financing Update
Update presentation on the IMC platform
English 14.9 KB
2025-06-30 08:01
Share Issue/Capital Change
Retail Offer
English 39.0 KB
2025-06-30 08:00
Share Issue/Capital Change
Placing
English 58.0 KB
2025-03-31 08:00
Legal Proceedings Report
Clinical Trial Update
English 17.3 KB
2025-03-27 08:00
Regulatory News Service
Innovate UK Grant Award
English 20.3 KB

Automate Your Workflow. Get a real-time feed of all CRISM Therapeutics Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CRISM Therapeutics Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
THERACRYF PLC Logo
Developing sulforaphane-based therapeutics for oncology and behavioural brain disorders.
United Kingdom TCF
Theranexus Logo
Biopharma developing drug candidates for rare neurological diseases like Batten disease.
France ALTHX
TME Pharma N.V. Logo
Clinical-stage biotech developing TME-targeting therapies for aggressive cancers.
Germany ALTME
Toleranzia AB Logo
Developing immune therapies for rare autoimmune diseases like myasthenia gravis.
Sweden TOL
Transgene Logo
Clinical-stage biotech using viral vectors for cancer vaccines and oncolytic viruses.
France TNG
Tvardi Therapeutics Inc. Logo United States of America TVRD
UCAR Logo
A nonprofit consortium managing atmospheric research and providing resources to the scientific community.
France ALUCR
Hong Kong N/A
Urteste S.A. Logo
Developing non-invasive urine tests for early detection & monitoring of multiple cancers.
Poland URT
VALIRX PLC Logo
Developing early-stage therapeutics & diagnostics for oncology and women's health.
United Kingdom VAL